Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Alistair Macdonald. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Alistair Macdonald har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:SYNH / Syneos Health Inc - Class A | Chief Executive Officer, Director | 228 131 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Alistair Macdonald. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Alistair Macdonald som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −26 761 | 228 131 | −10,50 | 80,75 | −2 160 951 | 18 421 578 | |
| 2022-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 8 880 | 254 892 | 3,61 | ||||
| 2022-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 8 209 | 246 012 | 3,45 | ||||
| 2022-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 36 727 | 237 803 | 18,27 | ||||
| 2022-01-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 30 498 | 201 076 | 17,88 | ||||
| 2022-01-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −15 028 | 170 578 | −8,10 | 86,09 | −1 293 761 | 14 685 060 | |
| 2022-01-12 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −10 154 | 185 606 | −5,19 | 93,69 | −951 328 | 17 389 426 | |
| 2021-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −35 553 | 0 | −100,00 | ||||
| 2021-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −7 032 | 195 760 | −3,47 | 88,49 | −622 269 | 17 322 998 |
| 2021-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −28 521 | 202 792 | −12,33 | 87,83 | −2 504 999 | 17 811 221 |
| 2021-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 35 553 | 231 313 | 18,16 | 42,76 | 1 520 246 | 9 890 944 |
| 2021-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −4 710 | 195 760 | −2,35 | 89,90 | −423 429 | 17 598 824 |
| 2021-06-03 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −4 889 | 0 | −100,00 | ||||
| 2021-06-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −4 889 | 200 470 | −2,38 | 88,20 | −431 210 | 17 681 454 |
| 2021-06-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 4 889 | 205 359 | 2,44 | 42,88 | 209 640 | 8 805 794 |
| 2021-04-12 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −14 039 | 200 470 | −6,54 | 80,00 | −1 123 120 | 16 037 600 |
| 2021-04-05 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −17 398 | 0 | −100,00 | ||||
| 2021-04-05 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −3 005 | 214 509 | −1,38 | 77,92 | −234 144 | 16 714 112 |
| 2021-04-05 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −13 720 | 217 514 | −5,93 | 77,61 | −1 064 823 | 16 881 479 |
| 2021-04-05 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −673 | 231 234 | −0,29 | 76,11 | −51 223 | 17 599 682 |
| 2021-04-05 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 17 398 | 231 907 | 8,11 | 40,12 | 698 008 | 9 304 109 |
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Performance Restricted Stock Units |
M - Exercise | −36 429 | 0 | −100,00 | ||||
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −17 122 | 214 509 | −7,39 | 75,50 | −1 292 711 | 16 195 430 | |
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | 36 429 | 231 631 | 18,66 | ||||
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −14 692 | 195 202 | −7,00 | 75,50 | −1 109 246 | 14 737 751 | |
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 4 308 | 209 894 | 2,10 | ||||
| 2021-03-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 7 993 | 205 586 | 4,05 | ||||
| 2021-02-18 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −12 450 | 197 593 | −5,93 | 78,59 | −978 446 | 15 528 834 | |
| 2021-02-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −278 | 210 043 | −0,13 | 77,11 | −21 438 | 16 197 256 |
| 2021-02-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −51 175 | 210 321 | −19,57 | 75,84 | −3 881 266 | 15 951 376 |
| 2021-02-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −13 044 | 261 496 | −4,75 | 75,17 | −980 544 | 19 657 177 |
| 2021-01-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 47 148 | 274 540 | 20,73 | ||||
| 2021-01-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −7 641 | 227 392 | −3,25 | 75,42 | −576 284 | 17 149 905 | |
| 2021-01-11 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −10 154 | 235 033 | −4,14 | 73,59 | −747 233 | 17 296 078 | |
| 2020-12-28 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −300 | 245 187 | −0,12 | 70,52 | −21 155 | 17 290 097 |
| 2020-12-28 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −1 200 | 245 487 | −0,49 | 70,02 | −84 020 | 17 188 263 |
| 2020-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −10 289 | 246 687 | −4,00 | 65,07 | −669 464 | 16 050 936 |
| 2020-08-04 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −4 178 | 256 976 | −1,60 | 65,06 | −271 821 | 16 718 859 | |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −9 467 | 0 | −100,00 | ||||
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −9 467 | 0 | −100,00 | ||||
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −18 934 | 18 934 | −50,00 | ||||
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −9 467 | 261 154 | −3,50 | 60,14 | −569 374 | 15 706 585 |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −9 467 | 261 154 | −3,50 | 60,14 | −569 374 | 15 706 585 |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 9 467 | 270 621 | 3,63 | 16,06 | 152 040 | 4 346 173 |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 9 467 | 270 621 | 3,63 | 16,06 | 152 040 | 4 346 173 |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −18 934 | 261 154 | −6,76 | 60,14 | −1 138 748 | 15 706 585 |
| 2020-07-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 18 934 | 280 088 | 7,25 | 16,06 | 304 080 | 4 498 213 |
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −5 173 | 0 | −100,00 | ||||
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −373 | 261 154 | −0,14 | 59,15 | −22 062 | 15 446 476 |
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −4 800 | 261 527 | −1,80 | 58,64 | −281 491 | 15 336 989 |
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 5 173 | 266 327 | 1,98 | 10,57 | 54 679 | 2 815 076 |
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −3 655 | 5 173 | −41,40 | ||||
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −3 655 | 261 154 | −1,38 | 58,21 | −212 747 | 15 200 991 |
| 2020-07-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 3 655 | 264 809 | 1,40 | 10,57 | 38 633 | 2 799 031 |
| 2020-04-15 |
|
4 | SYNH |
Syneos Health, Inc.
Performance Restricted Stock Units |
M - Exercise | −31 258 | 48 212 | −39,33 | ||||
| 2020-04-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 12 217 | 261 154 | 4,91 | ||||
| 2020-04-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | 31 258 | 248 937 | 14,36 | ||||
| 2020-02-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −12 451 | 217 679 | −5,41 | 66,51 | −828 116 | 14 477 830 | |
| 2020-01-29 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −13 545 | 230 130 | −5,56 | 62,69 | −849 136 | 14 426 850 | |
| 2020-01-22 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −1 293 | 243 675 | −0,53 | 63,83 | −82 532 | 15 553 775 | |
| 2020-01-17 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 48 770 | 244 968 | 24,86 | ||||
| 2020-01-09 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −10 155 | 196 198 | −4,92 | 59,96 | −608 894 | 11 764 032 | |
| 2019-08-02 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −4 178 | 206 353 | −1,98 | 48,99 | −204 680 | 10 109 233 | |
| 2019-07-02 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −1 022 | 210 531 | −0,48 | 51,46 | −52 592 | 10 833 925 | |
| 2019-02-19 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −12 451 | 211 553 | −5,56 | 54,74 | −681 568 | 11 580 411 | |
| 2019-02-15 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −8 143 | 0 | −100,00 | ||||
| 2019-02-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −8 143 | 224 004 | −3,51 | 53,00 | −431 579 | 11 872 212 |
| 2019-02-15 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 8 143 | 232 147 | 3,64 | 8,45 | 68 808 | 1 961 642 |
| 2019-02-07 |
|
4 | SYNH |
Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | −6 697 | 8 143 | −45,13 | ||||
| 2019-02-07 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −6 697 | 224 004 | −2,90 | 53,04 | −355 202 | 11 880 948 |
| 2019-02-07 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
M - Exercise | X | 6 697 | 230 701 | 2,99 | 8,45 | 56 590 | 1 949 423 |
| 2019-01-29 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −3 387 | 224 004 | −1,49 | 50,25 | −170 197 | 11 256 201 | |
| 2019-01-23 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −6 463 | 227 391 | −2,76 | 48,79 | −315 330 | 11 094 407 | |
| 2019-01-09 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 64 812 | 233 854 | 38,34 | ||||
| 2018-08-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −4 178 | 169 042 | −2,41 | 48,80 | −203 886 | 8 249 250 | |
| 2018-07-03 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −1 023 | 173 220 | −0,59 | 47,35 | −48 439 | 8 201 967 | |
| 2018-02-20 |
|
4 | SYNH |
Syneos Health, Inc.
Performance Restricted Stock Units |
A - Award | 79 470 | 79 470 | |||||
| 2018-02-20 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
A - Award | 79 470 | 174 243 | 83,85 | ||||
| 2018-01-30 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −3 387 | 94 773 | −3,45 | 40,75 | −138 020 | 3 862 000 | |
| 2018-01-22 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −1 293 | 98 160 | −1,30 | 40,90 | −52 884 | 4 014 744 | |
| 2017-09-19 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −2 348 | 99 453 | −2,31 | 54,60 | −128 201 | 5 430 134 |
| 2017-08-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −8 828 | 8 828 | −50,00 | |||
| 2017-08-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −8 828 | 101 801 | −7,98 | 55,65 | −491 261 | 5 665 022 |
| 2017-08-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 8 828 | 110 629 | 8,67 | 10,57 | 93 312 | 1 169 349 |
| 2017-08-14 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 36 429 | 36 429 | |||||
| 2017-08-03 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
M - Exercise | −16 500 | 0 | −100,00 | ||||
| 2017-08-03 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
M - Exercise | −32 421 | 0 | −100,00 | ||||
| 2017-08-03 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | 11 000 | 105 994 | 11,58 | ||||
| 2017-08-03 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | 21 614 | 94 994 | 29,45 | ||||
| 2017-08-03 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −4 193 | 101 801 | −3,96 | 55,85 | −234 179 | 5 685 586 | |
| 2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 088 | 73 380 | −1,46 | 58,55 | −63 702 | 4 296 399 |
| 2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −9 467 | 37 868 | −20,00 | |||
| 2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 467 | 74 468 | −11,28 | 58,36 | −552 456 | 4 345 655 |
| 2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 9 467 | 83 935 | 12,71 | 16,06 | 152 040 | 1 347 996 |
| 2017-05-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −9 467 | 37 868 | −20,00 | |||
| 2017-05-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 467 | 74 468 | −11,28 | 45,00 | −426 015 | 3 351 060 |
| 2017-05-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 9 467 | 83 935 | 12,71 | 16,06 | 152 040 | 1 347 996 |
| 2017-03-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −8 828 | 17 656 | −33,33 | |||
| 2017-03-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −8 828 | 74 468 | −10,60 | 45,00 | −397 260 | 3 351 060 |
| 2017-03-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 8 828 | 83 296 | 11,85 | 10,57 | 93 312 | 880 439 |
| 2017-01-30 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 32 421 | 32 421 | |||||
| 2017-01-30 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 21 614 | 74 468 | 40,89 | ||||
| 2017-01-23 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 375 | 52 854 | −2,54 | 50,50 | −69 438 | 2 669 127 |
| 2017-01-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −14 840 | 14 840 | −50,00 | |||
| 2017-01-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −14 840 | 54 229 | −21,49 | 52,19 | −774 440 | 2 829 995 |
| 2017-01-06 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 14 840 | 69 069 | 27,37 | 8,45 | 125 398 | 583 633 |
| 2016-08-18 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −8 828 | 26 484 | −25,00 | |||
| 2016-08-18 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −8 828 | 54 229 | −14,00 | 43,80 | −386 666 | 2 375 230 |
| 2016-08-18 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 8 828 | 63 057 | 16,28 | 10,57 | 93 312 | 666 512 |
| 2016-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
A - Award | 35 553 | 35 553 | |||||
| 2016-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 35 553 | 54 229 | 190,37 | ||||
| 2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −9 468 | 56 802 | −14,29 | |||
| 2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 468 | 18 676 | −33,64 | 40,19 | −380 500 | 750 551 |
| 2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 9 468 | 28 144 | 50,70 | 16,06 | 152 056 | 451 993 |
| 2016-07-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −1 023 | 18 676 | −5,19 | 38,13 | −39 007 | 712 116 | |
| 2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 16 500 | 16 500 | |||||
| 2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
A - Award | 4 889 | 4 889 | |||||
| 2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 11 000 | 19 699 | 126,45 | ||||
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −28 404 | 66 270 | −30,00 | |||
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −52 972 | 35 312 | −60,00 | |||
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −31 241 | 29 680 | −51,28 | |||
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −408 | 8 699 | −4,48 | 48,64 | −19 845 | 423 119 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 483 | 9 107 | −51,01 | 47,54 | −450 822 | 432 947 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −18 513 | 18 590 | −49,90 | 46,64 | −863 446 | 867 038 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 28 404 | 37 103 | 326,52 | 16,06 | 456 168 | 595 874 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −761 | 8 699 | −8,04 | 48,64 | −37 015 | 423 119 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −17 690 | 9 460 | −65,16 | 47,54 | −840 983 | 449 728 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −34 521 | 27 150 | −55,98 | 46,64 | −1 610 059 | 1 266 276 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 52 972 | 61 671 | 608,94 | 10,57 | 559 914 | 651 862 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −448 | 8 699 | −4,90 | 48,64 | −21 791 | 423 119 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −10 427 | 9 147 | −53,27 | 47,54 | −495 700 | 434 848 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −20 366 | 19 574 | −50,99 | 46,64 | −949 870 | 912 931 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 31 241 | 39 940 | 359,13 | 8,45 | 263 986 | 337 493 |
| 2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −46 982 | 8 699 | −84,38 | 48,64 | −2 285 204 | 423 119 |
| 2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −42 959 | 60 921 | −41,35 | |||
| 2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −600 | 55 681 | −1,07 | 45,54 | −27 321 | 2 535 434 |
| 2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −12 679 | 56 281 | −18,39 | 44,92 | −569 553 | 2 528 199 |
| 2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −29 680 | 68 960 | −30,09 | 44,49 | −1 320 523 | 3 068 168 |
| 2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 42 959 | 98 640 | 77,15 | 8,45 | 363 004 | 833 508 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −44 522 | 103 880 | −30,00 | |||
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −3 030 | 55 681 | −5,16 | 39,42 | −119 443 | 2 194 945 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −11 811 | 58 711 | −16,75 | 38,84 | −458 751 | 2 280 394 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −5 540 | 70 522 | −7,28 | 41,12 | −227 788 | 2 899 653 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 300 | 76 062 | −10,89 | 40,39 | −375 646 | 3 072 296 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −10 510 | 85 362 | −10,96 | 40,34 | −424 026 | 3 443 930 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 331 | 95 872 | −4,32 | 39,71 | −171 975 | 3 806 885 |
| 2015-09-29 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 44 522 | 100 203 | 79,96 | 8,45 | 376 211 | 846 715 |
| 2015-07-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
A - Award | 17 398 | 17 398 | |||||
| 2015-07-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 8 699 | 55 681 | 18,52 | ||||
| 2014-11-06 | 3 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
93 964 | ||||||||
| 2014-11-06 | 3 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
93 964 |